Wrist-based early alert for COVID cleared for sale in Europe

An MIT spinoff based in Boston and Milan in Italy has earned CE certification for software that flags respiratory infection in wearers of the company’s smartwatch devices.

Empatica announced the European go-ahead March 9, saying the new system, Aura, can detect COVID-19 in asymptomatic individuals.

The program is designed to run on Empatica’s Embrace Plus and E4 wristlets.

The company says that, in validation studies, Aura showed a sensitivity of 0.94 for identifying patients likely to be infected with H1N1, Rhinovirus and SARS-CoV-2.

Empatica says it’s working on obtaining the FDA’s OK for Aura after having partnered with HHS and Stanford University on validating Aura on U.S. healthcare workers.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”